id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-N-1383-0042,FDA,FDA-2020-N-1383,Revocation of Methods of Analysis Regulation,Rule,Final Rule,2026-02-19T05:00:00Z,2026,2,2026-02-19T05:00:00Z,,2026-02-19T20:49:20Z,2026-03285,0,0,09000064b91bd38a
FDA-2020-N-1383-0014,FDA,FDA-2020-N-1383,Summary of FDA AOAC meeting,Other,Summary (SUM),2022-09-08T04:00:00Z,2022,9,2022-09-08T04:00:00Z,,2022-09-08T15:02:28Z,,0,0,09000064852cca12
FDA-2020-N-1383-0001,FDA,FDA-2020-N-1383,Revocation of Methods of Analysis Regulation,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2022-07-15T04:00:00Z,2022,7,2022-07-15T04:00:00Z,2022-09-29T03:59:59Z,2022-09-30T01:00:40Z,2022-15109,0,0,09000064851ccecc